Suppr超能文献

人 mTOR 复合物 I 的结构及其对雷帕霉素抑制的影响。

Structure of the human mTOR complex I and its implications for rapamycin inhibition.

机构信息

Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Mol Cell. 2010 Jun 11;38(5):768-74. doi: 10.1016/j.molcel.2010.05.017.

Abstract

The mammalian target of rapamycin complex 1 (mTORC1) regulates cell growth in response to the nutrient and energy status of the cell, and its deregulation is common in human cancers. Little is known about the overall architecture and subunit organization of this essential signaling complex. We have determined the three-dimensional (3D) structure of the fully assembled human mTORC1 by cryo-electron microscopy (cryo-EM). Our analyses reveal that mTORC1 is an obligate dimer with an overall rhomboid shape and a central cavity. The dimeric interfaces are formed by interlocking interactions between the mTOR and raptor subunits. Extended incubation with FKBP12-rapamycin compromises the structural integrity of mTORC1 in a stepwise manner, leading us to propose a model in which rapamycin inhibits mTORC1-mediated phosphorylation of 4E-BP1 and S6K1 through different mechanisms.

摘要

哺乳动物雷帕霉素靶蛋白复合物 1(mTORC1)可响应细胞的营养和能量状态调节细胞生长,其失调在人类癌症中很常见。目前对于这种重要信号复合物的整体结构和亚基组成知之甚少。我们通过冷冻电镜(cryo-EM)确定了完全组装的人 mTORC1 的三维(3D)结构。我们的分析表明,mTORC1 是一个必需的二聚体,具有菱形整体形状和中央腔。二聚体界面是通过 mTOR 和 raptor 亚基之间的互锁相互作用形成的。与 FKBP12-雷帕霉素的长时间孵育会以逐步的方式破坏 mTORC1 的结构完整性,这使我们提出了一个模型,其中雷帕霉素通过不同的机制抑制 mTORC1 介导的 4E-BP1 和 S6K1 的磷酸化。

相似文献

1
Structure of the human mTOR complex I and its implications for rapamycin inhibition.
Mol Cell. 2010 Jun 11;38(5):768-74. doi: 10.1016/j.molcel.2010.05.017.
2
PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.
J Biol Chem. 2007 Jul 6;282(27):20036-44. doi: 10.1074/jbc.M702376200. Epub 2007 May 17.
3
Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.
J Biol Chem. 2010 Dec 3;285(49):38362-73. doi: 10.1074/jbc.M110.141168. Epub 2010 Oct 11.
4
Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40.
Nature. 2017 Dec 21;552(7685):368-373. doi: 10.1038/nature25023. Epub 2017 Dec 13.
5
4.4 Å Resolution Cryo-EM structure of human mTOR Complex 1.
Protein Cell. 2016 Dec;7(12):878-887. doi: 10.1007/s13238-016-0346-6. Epub 2016 Dec 1.
6
Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth.
Mol Cell Biol. 2009 Aug;29(15):4308-24. doi: 10.1128/MCB.01665-08. Epub 2009 Jun 1.
7
The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
J Biol Chem. 2007 Jul 13;282(28):20329-39. doi: 10.1074/jbc.M702636200. Epub 2007 May 21.
8
Curcumin disrupts the Mammalian target of rapamycin-raptor complex.
Cancer Res. 2009 Feb 1;69(3):1000-8. doi: 10.1158/0008-5472.CAN-08-2367. Epub 2009 Jan 27.
9
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Acta Physiol (Oxf). 2009 May;196(1):65-80. doi: 10.1111/j.1748-1716.2009.01972.x. Epub 2009 Feb 19.
10
Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy.
Cell Cycle. 2009 Feb 15;8(4):567-72. doi: 10.4161/cc.8.4.7659. Epub 2009 Feb 18.

引用本文的文献

1
The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies.
Biomedicines. 2025 May 28;13(6):1319. doi: 10.3390/biomedicines13061319.
4
TSC-mTORC1 Pathway in Postnatal V-SVZ Neurodevelopment.
Biomolecules. 2025 Apr 12;15(4):573. doi: 10.3390/biom15040573.
5
(-)-Epicatechin Rescues Memory Deficits by Activation of Autophagy in a Mouse Model of Tauopathies.
MedComm (2020). 2025 Mar 24;6(4):e70144. doi: 10.1002/mco2.70144. eCollection 2025 Apr.
6
JC virus small tumor antigen promotes S phase entry and cell cycle progression.
Tumour Virus Res. 2024 Dec;18:200298. doi: 10.1016/j.tvr.2024.200298. Epub 2024 Nov 23.
8
Mitophagy Unveiled: Exploring the Nexus of Mitochondrial Health and Neuroendocrinopathy.
J Mol Neurosci. 2024 Nov 8;74(4):107. doi: 10.1007/s12031-024-02280-w.
9
mTORC1 signaling and diabetic kidney disease.
Diabetol Int. 2024 Jun 20;15(4):707-718. doi: 10.1007/s13340-024-00738-1. eCollection 2024 Oct.

本文引用的文献

1
Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats.
Nature. 2010 Jan 7;463(7277):118-21. doi: 10.1038/nature08648. Epub 2009 Dec 20.
2
Molecular mechanisms of mTOR-mediated translational control.
Nat Rev Mol Cell Biol. 2009 May;10(5):307-18. doi: 10.1038/nrm2672. Epub 2009 Apr 2.
3
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.
PLoS Biol. 2009 Feb 10;7(2):e38. doi: 10.1371/journal.pbio.1000038.
4
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.
J Biol Chem. 2009 Mar 20;284(12):8023-32. doi: 10.1074/jbc.M900301200. Epub 2009 Jan 15.
5
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation.
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17414-9. doi: 10.1073/pnas.0809136105. Epub 2008 Oct 27.
6
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.
Science. 2008 Jun 13;320(5882):1496-501. doi: 10.1126/science.1157535. Epub 2008 May 22.
7
Structure of TOR and its complex with KOG1.
Mol Cell. 2007 Aug 3;27(3):509-16. doi: 10.1016/j.molcel.2007.05.040.
8
Defining the role of mTOR in cancer.
Cancer Cell. 2007 Jul;12(1):9-22. doi: 10.1016/j.ccr.2007.05.008.
9
PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.
J Biol Chem. 2007 Jul 6;282(27):20036-44. doi: 10.1074/jbc.M702376200. Epub 2007 May 17.
10
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.
Mol Cell. 2007 Mar 23;25(6):903-15. doi: 10.1016/j.molcel.2007.03.003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验